LIPRIDIA Trademark

Trademark Overview

On Wednesday, December 28, 2016, a trademark application was filed for LIPRIDIA with the United States Patent and Trademark Office. The USPTO has given the LIPRIDIA trademark a serial number of 87282999. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2020. This trademark is owned by Cadila Healthcare Limited. The LIPRIDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy
lipridia

General Information

Serial Number87282999
Word MarkLIPRIDIA
Filing DateWednesday, December 28, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCadila Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGujarat 380015
IN
Party NameCadila Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGujarat
IN

Trademark Events

Event DateEvent Description
Monday, August 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 8, 2020EXTENSION 5 GRANTED
Monday, December 30, 2019EXTENSION 5 FILED
Wednesday, January 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 30, 2019TEAS EXTENSION RECEIVED
Friday, June 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2019EXTENSION 4 GRANTED
Wednesday, June 26, 2019EXTENSION 4 FILED
Wednesday, June 26, 2019TEAS EXTENSION RECEIVED
Friday, January 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 2, 2019EXTENSION 3 GRANTED
Wednesday, January 2, 2019EXTENSION 3 FILED
Wednesday, January 2, 2019TEAS EXTENSION RECEIVED
Saturday, June 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 28, 2018EXTENSION 2 GRANTED
Thursday, June 28, 2018EXTENSION 2 FILED
Thursday, June 28, 2018TEAS EXTENSION RECEIVED
Friday, December 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 27, 2017EXTENSION 1 GRANTED
Wednesday, December 27, 2017EXTENSION 1 FILED
Wednesday, December 27, 2017TEAS EXTENSION RECEIVED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 25, 2017ASSIGNED TO EXAMINER
Tuesday, January 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 31, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

lipridia hypertriglycedemia induced lipodystrophy nash dyslipidemia preparations treatment diabetes pharmaceutical